Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.21.2
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Schedule of Stock Options Activity

The following table summarizes stock options activity during the six months ended June 30, 2021 for the Amended 2010 Plan, the Amended 2010 Directors’ Plan and the 2018 Stock Plan (in thousands, except per share data):

    Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life
(in years)		     Total Intrinsic Value  
Outstanding as of January 1, 2021     3,795     $ 2.21       3.4     $ 26,441  
Granted     675       9.13       5.1       -  
Forfeited     (92 )     5.31       -       -  
Outstanding as of June 30, 2021     4,378     $ 3.06       3.2     $ 16,182  
Options vested and exercisable     3,573     $ 2.22       2.7     $ 15,183  
Summary of Weighted Average Assumptions Used In Determining Fair Value of Options

The following table summarizes weighted average assumptions used in determining the fair value of the options at the date of grant during the six months ended June 30, 2021:

    For the six months ended  
    June 30, 2021  
Exercise price   $ 9.13  
Expected term (years)     3.5  
Expected stock price volatility     83 %
Risk-free rate of interest     0.6 %
Expected dividend yield (per share)     0 %
Schedule of Warrant Activity

    Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life
(in years)		  
Outstanding as of January 1, 2021     450     $ 3.22       2.7  
Warrants granted     455       12.83       3.0  
Outstanding as of June 30, 2021     905     $ 8.05       2.4  
Warrants vested and exercisable     815     $ 8.61       2.4  
Summary of Weighted Average Assumptions Used in Determining Fair Value of Warrants

The following table summarizes weighted average assumptions used in determining the fair value of the warrants at the date of grant during the six months ended June 30, 2021:

    For the six months ended  
    June 30, 2021  
Exercise price   $ 12.83  
Expected term (years)     3.0  
Expected stock price volatility     81 %
Risk-free rate of interest     0.2 %
Expected dividend yield (per share)     0 %